S&P 500   3,855.36
DOW   30,960.00
QQQ   328.11
pixel
S&P 500   3,855.36
DOW   30,960.00
QQQ   328.11
pixel
S&P 500   3,855.36
DOW   30,960.00
QQQ   328.11
pixel
S&P 500   3,855.36
DOW   30,960.00
QQQ   328.11
pixel
Log in
NYSE:VAR

Varian Medical Systems Competitors

$175.33
-0.14 (-0.08 %)
(As of 01/25/2021 12:00 AM ET)
Add
Compare
Today's Range
$175.25
Now: $175.33
$175.60
50-Day Range
$174.13
MA: $175.10
$175.86
52-Week Range
$89.62
Now: $175.33
$176.19
Volume572,822 shs
Average Volume750,308 shs
Market Capitalization$16.02 billion
P/E Ratio59.84
Dividend YieldN/A
Beta1.06

Competitors

Varian Medical Systems (NYSE:VAR) Vs. ABT, MDT, SYK, ISRG, BDX, and EW

Should you be buying VAR stock or one of its competitors? Companies in the sub-industry of "health care equipment" are considered alternatives and competitors to Varian Medical Systems, including Abbott Laboratories (ABT), Medtronic (MDT), Stryker (SYK), Intuitive Surgical (ISRG), Becton, Dickinson and (BDX), and Edwards Lifesciences (EW).

Abbott Laboratories (NYSE:ABT) and Varian Medical Systems (NYSE:VAR) are both large-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their earnings, profitability, analyst recommendations, valuation, risk, dividends and institutional ownership.

Profitability

This table compares Abbott Laboratories and Varian Medical Systems' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Abbott Laboratories10.50%18.19%8.29%
Varian Medical Systems8.50%18.45%8.08%

Valuation & Earnings

This table compares Abbott Laboratories and Varian Medical Systems' gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Abbott Laboratories$31.90 billion6.37$3.69 billion$3.2435.41
Varian Medical Systems$3.17 billion5.06$269.20 million$3.9144.84

Abbott Laboratories has higher revenue and earnings than Varian Medical Systems. Abbott Laboratories is trading at a lower price-to-earnings ratio than Varian Medical Systems, indicating that it is currently the more affordable of the two stocks.

Risk and Volatility

Abbott Laboratories has a beta of 0.83, meaning that its stock price is 17% less volatile than the S&P 500. Comparatively, Varian Medical Systems has a beta of 1.06, meaning that its stock price is 6% more volatile than the S&P 500.

Analyst Recommendations

This is a breakdown of recent ratings and recommmendations for Abbott Laboratories and Varian Medical Systems, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Abbott Laboratories121302.75
Varian Medical Systems36001.67

Abbott Laboratories currently has a consensus target price of $115.6875, indicating a potential upside of 0.84%. Varian Medical Systems has a consensus target price of $148.2778, indicating a potential downside of 15.43%. Given Abbott Laboratories' stronger consensus rating and higher probable upside, analysts clearly believe Abbott Laboratories is more favorable than Varian Medical Systems.

Insider & Institutional Ownership

72.6% of Abbott Laboratories shares are owned by institutional investors. Comparatively, 87.0% of Varian Medical Systems shares are owned by institutional investors. 1.7% of Abbott Laboratories shares are owned by insiders. Comparatively, 0.8% of Varian Medical Systems shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Summary

Abbott Laboratories beats Varian Medical Systems on 10 of the 14 factors compared between the two stocks.

Medtronic (NYSE:MDT) and Varian Medical Systems (NYSE:VAR) are both large-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their earnings, profitability, analyst recommendations, valuation, risk, dividends and institutional ownership.

Profitability

This table compares Medtronic and Varian Medical Systems' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Medtronic12.69%9.71%5.30%
Varian Medical Systems8.50%18.45%8.08%

Valuation & Earnings

This table compares Medtronic and Varian Medical Systems' gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Medtronic$28.91 billion5.44$4.79 billion$4.5925.47
Varian Medical Systems$3.17 billion5.06$269.20 million$3.9144.84

Medtronic has higher revenue and earnings than Varian Medical Systems. Medtronic is trading at a lower price-to-earnings ratio than Varian Medical Systems, indicating that it is currently the more affordable of the two stocks.

Risk and Volatility

Medtronic has a beta of 0.7, meaning that its stock price is 30% less volatile than the S&P 500. Comparatively, Varian Medical Systems has a beta of 1.06, meaning that its stock price is 6% more volatile than the S&P 500.

Analyst Recommendations

This is a breakdown of recent ratings and recommmendations for Medtronic and Varian Medical Systems, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Medtronic032012.92
Varian Medical Systems36001.67

Medtronic currently has a consensus target price of $122.2963, indicating a potential upside of 4.62%. Varian Medical Systems has a consensus target price of $148.2778, indicating a potential downside of 15.43%. Given Medtronic's stronger consensus rating and higher probable upside, analysts clearly believe Medtronic is more favorable than Varian Medical Systems.

Insider & Institutional Ownership

79.2% of Medtronic shares are owned by institutional investors. Comparatively, 87.0% of Varian Medical Systems shares are owned by institutional investors. 0.5% of Medtronic shares are owned by insiders. Comparatively, 0.8% of Varian Medical Systems shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Summary

Medtronic beats Varian Medical Systems on 9 of the 15 factors compared between the two stocks.

Stryker (NYSE:SYK) and Varian Medical Systems (NYSE:VAR) are both large-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their earnings, profitability, analyst recommendations, valuation, risk, dividends and institutional ownership.

Profitability

This table compares Stryker and Varian Medical Systems' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Stryker12.35%20.94%8.77%
Varian Medical Systems8.50%18.45%8.08%

Valuation & Earnings

This table compares Stryker and Varian Medical Systems' gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Stryker$14.88 billion6.05$2.08 billion$8.2629.00
Varian Medical Systems$3.17 billion5.06$269.20 million$3.9144.84

Stryker has higher revenue and earnings than Varian Medical Systems. Stryker is trading at a lower price-to-earnings ratio than Varian Medical Systems, indicating that it is currently the more affordable of the two stocks.

Risk and Volatility

Stryker has a beta of 0.87, meaning that its stock price is 13% less volatile than the S&P 500. Comparatively, Varian Medical Systems has a beta of 1.06, meaning that its stock price is 6% more volatile than the S&P 500.

Analyst Recommendations

This is a breakdown of recent ratings and recommmendations for Stryker and Varian Medical Systems, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Stryker271412.58
Varian Medical Systems36001.67

Stryker currently has a consensus target price of $227.4783, indicating a potential downside of 5.04%. Varian Medical Systems has a consensus target price of $148.2778, indicating a potential downside of 15.43%. Given Stryker's stronger consensus rating and higher probable upside, analysts clearly believe Stryker is more favorable than Varian Medical Systems.

Insider & Institutional Ownership

71.5% of Stryker shares are owned by institutional investors. Comparatively, 87.0% of Varian Medical Systems shares are owned by institutional investors. 6.8% of Stryker shares are owned by insiders. Comparatively, 0.8% of Varian Medical Systems shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Summary

Stryker beats Varian Medical Systems on 12 of the 15 factors compared between the two stocks.

Intuitive Surgical (NASDAQ:ISRG) and Varian Medical Systems (NYSE:VAR) are both large-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their earnings, profitability, analyst recommendations, valuation, risk, dividends and institutional ownership.

Risk and Volatility

Intuitive Surgical has a beta of 0.98, meaning that its stock price is 2% less volatile than the S&P 500. Comparatively, Varian Medical Systems has a beta of 1.06, meaning that its stock price is 6% more volatile than the S&P 500.

Analyst Recommendations

This is a breakdown of recent ratings and recommmendations for Intuitive Surgical and Varian Medical Systems, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Intuitive Surgical381002.33
Varian Medical Systems36001.67

Intuitive Surgical currently has a consensus target price of $736.0588, indicating a potential downside of 2.12%. Varian Medical Systems has a consensus target price of $148.2778, indicating a potential downside of 15.43%. Given Intuitive Surgical's stronger consensus rating and higher probable upside, analysts clearly believe Intuitive Surgical is more favorable than Varian Medical Systems.

Profitability

This table compares Intuitive Surgical and Varian Medical Systems' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Intuitive Surgical24.45%12.08%10.44%
Varian Medical Systems8.50%18.45%8.08%

Insider & Institutional Ownership

86.5% of Intuitive Surgical shares are owned by institutional investors. Comparatively, 87.0% of Varian Medical Systems shares are owned by institutional investors. 1.6% of Intuitive Surgical shares are owned by insiders. Comparatively, 0.8% of Varian Medical Systems shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Valuation & Earnings

This table compares Intuitive Surgical and Varian Medical Systems' gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Intuitive Surgical$4.48 billion19.74$1.38 billion$9.9575.58
Varian Medical Systems$3.17 billion5.06$269.20 million$3.9144.84

Intuitive Surgical has higher revenue and earnings than Varian Medical Systems. Varian Medical Systems is trading at a lower price-to-earnings ratio than Intuitive Surgical, indicating that it is currently the more affordable of the two stocks.

Summary

Intuitive Surgical beats Varian Medical Systems on 11 of the 14 factors compared between the two stocks.

Varian Medical Systems (NYSE:VAR) and Becton, Dickinson and (NYSE:BDX) are both large-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, risk, analyst recommendations, dividends, institutional ownership, valuation and profitability.

Risk and Volatility

Varian Medical Systems has a beta of 1.06, meaning that its stock price is 6% more volatile than the S&P 500. Comparatively, Becton, Dickinson and has a beta of 0.79, meaning that its stock price is 21% less volatile than the S&P 500.

Analyst Ratings

This is a breakdown of recent recommendations for Varian Medical Systems and Becton, Dickinson and, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Varian Medical Systems36001.67
Becton, Dickinson and07702.50

Varian Medical Systems currently has a consensus target price of $148.2778, indicating a potential downside of 15.43%. Becton, Dickinson and has a consensus target price of $279.6667, indicating a potential upside of 7.46%. Given Becton, Dickinson and's stronger consensus rating and higher possible upside, analysts plainly believe Becton, Dickinson and is more favorable than Varian Medical Systems.

Profitability

This table compares Varian Medical Systems and Becton, Dickinson and's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Varian Medical Systems8.50%18.45%8.08%
Becton, Dickinson and5.11%13.30%5.60%

Insider and Institutional Ownership

87.0% of Varian Medical Systems shares are held by institutional investors. Comparatively, 83.2% of Becton, Dickinson and shares are held by institutional investors. 0.8% of Varian Medical Systems shares are held by insiders. Comparatively, 0.8% of Becton, Dickinson and shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Valuation and Earnings

This table compares Varian Medical Systems and Becton, Dickinson and's gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Varian Medical Systems$3.17 billion5.06$269.20 million$3.9144.84
Becton, Dickinson and$17.12 billion4.42$874 million$10.2025.51

Becton, Dickinson and has higher revenue and earnings than Varian Medical Systems. Becton, Dickinson and is trading at a lower price-to-earnings ratio than Varian Medical Systems, indicating that it is currently the more affordable of the two stocks.

Varian Medical Systems (NYSE:VAR) and Edwards Lifesciences (NYSE:EW) are both large-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, risk, analyst recommendations, dividends, institutional ownership, valuation and profitability.

Risk and Volatility

Varian Medical Systems has a beta of 1.06, meaning that its stock price is 6% more volatile than the S&P 500. Comparatively, Edwards Lifesciences has a beta of 0.97, meaning that its stock price is 3% less volatile than the S&P 500.

Analyst Ratings

This is a breakdown of recent recommendations for Varian Medical Systems and Edwards Lifesciences, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Varian Medical Systems36001.67
Edwards Lifesciences271202.48

Varian Medical Systems currently has a consensus target price of $148.2778, indicating a potential downside of 15.43%. Edwards Lifesciences has a consensus target price of $90.8704, indicating a potential upside of 5.80%. Given Edwards Lifesciences' stronger consensus rating and higher possible upside, analysts plainly believe Edwards Lifesciences is more favorable than Varian Medical Systems.

Profitability

This table compares Varian Medical Systems and Edwards Lifesciences' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Varian Medical Systems8.50%18.45%8.08%
Edwards Lifesciences18.18%29.00%18.10%

Insider and Institutional Ownership

87.0% of Varian Medical Systems shares are held by institutional investors. Comparatively, 80.9% of Edwards Lifesciences shares are held by institutional investors. 0.8% of Varian Medical Systems shares are held by insiders. Comparatively, 1.5% of Edwards Lifesciences shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Valuation and Earnings

This table compares Varian Medical Systems and Edwards Lifesciences' gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Varian Medical Systems$3.17 billion5.06$269.20 million$3.9144.84
Edwards Lifesciences$4.35 billion12.31$1.05 billion$1.8646.18

Edwards Lifesciences has higher revenue and earnings than Varian Medical Systems. Varian Medical Systems is trading at a lower price-to-earnings ratio than Edwards Lifesciences, indicating that it is currently the more affordable of the two stocks.

Summary

Edwards Lifesciences beats Varian Medical Systems on 11 of the 14 factors compared between the two stocks.


Varian Medical Systems Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
Abbott Laboratories logo
ABT
Abbott Laboratories
2.4$114.72-1.6%$203.33 billion$31.90 billion60.70Upcoming Earnings
Medtronic logo
MDT
Medtronic
2.7$116.90-0.3%$157.35 billion$28.91 billion44.62
Stryker logo
SYK
Stryker
2.0$239.55-0.2%$90.02 billion$14.88 billion51.96Upcoming Earnings
Intuitive Surgical logo
ISRG
Intuitive Surgical
1.7$752.01-1.1%$88.40 billion$4.48 billion85.65Earnings Announcement
Becton, Dickinson and logo
BDX
Becton, Dickinson and
2.0$260.24-0.6%$75.69 billion$17.12 billion95.33Dividend Announcement
News Coverage
Edwards Lifesciences logo
EW
Edwards Lifesciences
1.6$85.89-0.4%$53.53 billion$4.35 billion68.71Upcoming Earnings
Boston Scientific logo
BSX
Boston Scientific
2.2$36.78-0.7%$52.67 billion$10.74 billion14.09
IDEXX Laboratories logo
IDXX
IDEXX Laboratories
1.5$489.21-0.7%$41.73 billion$2.41 billion85.23Upcoming Earnings
Baxter International logo
BAX
Baxter International
2.3$80.10-0.7%$40.92 billion$11.36 billion45.51
DexCom logo
DXCM
DexCom
1.9$376.39-1.7%$36.14 billion$1.48 billion155.53Insider Selling
ResMed logo
RMD
ResMed
1.4$221.68-2.8%$32.12 billion$2.96 billion47.57Upcoming Earnings
Hologic logo
HOLX
Hologic
1.9$76.34-0.8%$19.62 billion$3.78 billion18.18Upcoming Earnings
Insulet logo
PODD
Insulet
1.3$288.91-0.5%$19.05 billion$738.20 million656.63
Teleflex logo
TFX
Teleflex
2.0$382.14-1.1%$17.80 billion$2.60 billion49.18
STERIS logo
STE
STERIS
2.1$190.41-0.9%$16.25 billion$3.03 billion38.62Upcoming Earnings
Abiomed logo
ABMD
Abiomed
1.5$348.32-0.1%$15.74 billion$840.88 million76.55Upcoming Earnings
Masimo logo
MASI
Masimo
1.4$257.09-2.6%$14.15 billion$937.84 million66.78
Hill-Rom logo
HRC
Hill-Rom
2.0$101.16-1.7%$6.71 billion$2.88 billion30.47
Globus Medical logo
GMED
Globus Medical
1.4$64.44-1.4%$6.36 billion$785.37 million70.04
Integra LifeSciences logo
IART
Integra LifeSciences
1.4$69.36-0.1%$5.85 billion$1.52 billion103.52
NuVasive logo
NUVA
NuVasive
1.5$56.80-0.2%$2.91 billion$1.17 billion-258.18
AtriCure logo
ATRC
AtriCure
1.3$58.30-1.3%$2.62 billion$230.81 million-50.70
Integer logo
ITGR
Integer
2.3$78.15-1.2%$2.57 billion$1.26 billion35.52
Cardiovascular Systems logo
CSII
Cardiovascular Systems
1.3$46.51-0.3%$1.87 billion$236.54 million-70.47
Alphatec logo
ATEC
Alphatec
0.8$14.92-0.7%$1.17 billion$113.43 million-13.56
CryoLife logo
CRY
CryoLife
1.5$24.96-1.2%$969.87 million$276.22 million-65.68
Orthofix Medical logo
OFIX
Orthofix Medical
1.2$44.94-2.2%$868.77 million$459.95 million37.45
AngioDynamics logo
ANGO
AngioDynamics
1.6$18.55-1.9%$704.04 million$264.16 million-4.15
Surmodics logo
SRDX
Surmodics
1.5$46.33-1.0%$633.89 million$94.86 million579.13News Coverage
Accuray logo
ARAY
Accuray
2.2$5.08-0.6%$463.67 million$382.93 million36.29Upcoming Earnings
Invacare logo
IVC
Invacare
1.6$9.92-0.1%$341.43 million$927.96 million-8.06
Rockwell Medical logo
RMTI
Rockwell Medical
1.3$1.46-2.7%$136.62 million$61.30 million-3.40
This page was last updated on 1/26/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.